You have read all your free articles, to continue reading subscribe to read the rest of this content.
The boards of Coegin Pharma and Follicum have assumed a merger plan in order to implement a merger of Coegin Pharma and Follicum through a limited company legal fusion. The fusion will be implemented by Follicum being absorbed by Coegin Pharma. Read more: Follicum pauses all of its developmentAlready a…
The European Commission has granted marketing authorization for Vyepti in the European Union for the prophylactic treatment of migraine in adults who have at least four migraine days per month. The approval follows the positive opinion on November 11th, 2021 from the European Medicines Agency’sAlready a subscriber Login You have…
The Uppsala-based company has been named Alumni company at Uppsala Innovation Centre. Sprint Bioscience was accepted to the incubator Uppsala Innovation Centre’s (UIC) program when its product idea and business plan was just in its infancy. Today the company has finished the program at UIC and Already a subscriber Login…
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Calquence (acalabrutinib) as a monotherapy treatment for adult patients with chronic lymphocytic leukaemia (CLL). “This is an important regulatory milestone for our work in haematology and for patieAlready a subscriber Login You have read all your…
